These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7681916

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparative effects of the potassium channel openers cromakalim and pinacidil and the cromakalim analog U-89232 on isolated vascular and cardiac tissue.
    Norman NR, Toombs CF, Khan SA, Buchanan LV, Cimini MG, Gibson JK, Meisheri KD, Shebuski RJ.
    Pharmacology; 1994 Aug; 49(2):86-95. PubMed ID: 7972325
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
    Grover GJ, McCullough JR, Henry DE, Conder ML, Sleph PG.
    J Pharmacol Exp Ther; 1989 Oct; 251(1):98-104. PubMed ID: 2507775
    [Abstract] [Full Text] [Related]

  • 27. Modulation of rabbit aortic Ca(2+)-activated K+ channels by pinacidil, cromakalim, and glibenclamide.
    Gelband GH, McCullough JR.
    Am J Physiol; 1993 May; 264(5 Pt 1):C1119-27. PubMed ID: 8498475
    [Abstract] [Full Text] [Related]

  • 28. Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil.
    Wilson C, Coldwell MC, Howlett DR, Cooper SM, Hamilton TC.
    Eur J Pharmacol; 1988 Aug 02; 152(3):331-9. PubMed ID: 2851450
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effects of pinacidil on myocardial blood flow and infarct size after acute left anterior descending coronary artery occlusion and reperfusion in awake dogs with and without a coexisting left circumflex coronary artery stenosis.
    Sakamoto S, Liang CS, Stone CK, Hood WB.
    J Cardiovasc Pharmacol; 1989 Nov 02; 14(5):747-55. PubMed ID: 2481189
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Evidence that pinacidil may promote the opening of ATP-sensitive K+ channels yet inhibit the opening of Ca2(+)-activated K+ channels in K(+)-contracted canine mesenteric artery.
    Masuzawa K, Matsuda T, Asano M.
    Br J Pharmacol; 1990 May 02; 100(1):143-9. PubMed ID: 2115387
    [Abstract] [Full Text] [Related]

  • 38. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
    Piper I, Minshall E, Downing SJ, Hollingsworth M, Sadraei H.
    Br J Pharmacol; 1990 Dec 02; 101(4):901-7. PubMed ID: 2128195
    [Abstract] [Full Text] [Related]

  • 39. Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915.
    Cook NS, Quast U, Hof RP, Baumlin Y, Pally C.
    J Cardiovasc Pharmacol; 1988 Jan 02; 11(1):90-9. PubMed ID: 2450263
    [Abstract] [Full Text] [Related]

  • 40. [Effect of potassium channel openers on hypoxic pulmonary vasoconstriction].
    Matsumoto H, Nakano H, Akiba Y, Osanai S, Tobise K, Onodera S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug 02; 30(8):1488-95. PubMed ID: 1434222
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.